| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED) (NCT00034983) | Merck Sharp & Dohme LLC | 2001-10-29 |
| Brain Function in Mentally Ill Adolescents (NCT00025857) | National Institute of Mental Health (NIMH) | 2001-10-22 |
| Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders (NCT00018057) | National Institute of Mental Health (NIMH) | 2001-10-02 |
| Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones (NCT00562367) | Massachusetts General Hospital | 2001-10-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059) (NCT00035009) | Merck Sharp & Dohme LLC | 2001-09-20 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) (NCT00035282) | Merck Sharp & Dohme LLC | 2001-09-01 |
| Stress Generation and Recurrent Depression: The Role of Differential Treatment Response (NCT00745017) | Centre for Addiction and Mental Health | 2001-07-01 |
| The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients (NCT00581009) | University of California, Irvine | 2001-05-30 |
| Treatment of Severe Depressive Illness by Targeted Brain Surgery (NCT01101373) | University of British Columbia | 2000-10-01 |
| Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) (NCT00533832) | Cyberonics, Inc. | 2000-07-01 |
| Fluoxetine vs. Brief Psychotherapy for Major Depression (NCT00714779) | University of Turku | 2000-01-01 |
| Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group (NCT00265291) | National Institute of General Medical Sciences (NIGMS) | 1999-11-01 |
| Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder (NCT00229398) | Sheba Medical Center | 1998-11-01 |
| Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy (NCT00209066) | Emory University | 1998-11-01 |
| Treatment for Adolescents With Depression Study (TADS) (NCT00006286) | National Institute of Mental Health (NIMH) | 1998-09-01 |
| Metyrapone as Additive Treatment in Major Depression (NCT00125554) | Universitätsklinikum Hamburg-Eppendorf | 1998-05-01 |
| Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood? (NCT00208897) | Emory University | 1997-12-01 |
| Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder (NCT00000375) | National Institute of Mental Health (NIMH) | 1997-02-01 |
| Neurophysiologic Monitoring of Antidepressant Treatment (NCT01360190) | University of California, Los Angeles | 1994-08-01 |
| Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder (NCT00075257) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder (NCT00072774) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder (NCT00087737) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| The Effectiveness of Idazoxan in Treating TRD (NCT00294944) | Sheba Medical Center | |
| A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder (NCT00073203) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder (NCT00092911) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder (NCT00290914) | Pharmacology Research Institute | |
| Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder (NCT00073762) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Individual Patient Esmethadone (REL-1017) Expanded Access Program (NCT06009003) | Relmada Therapeutics, Inc. | |
| Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder (NCT00090649) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial (NCT00071708) | Eli Lilly and Company | |
| Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder (NCT00063206) | Wyeth is now a wholly owned subsidiary of Pfizer | |